Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.
Lewiecki
E Michael
EM
New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM 87106, USA. LEWIECKI@aol.com
D015502:Absorptiometry, Photon; D015519:Bone Density / Q000502:physiology*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D016723:Bone Remodeling / Q000502:physiology; D000069449:Cinacalcet; D004164:Diphosphonates / Q000627:therapeutic use; D050723:Fractures, Bone / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology* / Q000628:therapy; D009281:Naphthalenes / Q000627:therapeutic use; D010024:Osteoporosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D016105:Parathyroidectomy; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D009281:Naphthalenes; D000069449:Cinacalcet